Clinical
‘Your insights have been invaluable’
Assistant minister and pharmacist Emma McBride says the government will reveal its plan to tackle critical workforce shortages, as hospital pharmacy services plummet due to supply gaps The Federal …
‘This work strengthens our national frameworks’
Slade Pharmacy will present eight abstracts at the 2025 Advanced Pharmacy Australia (AdPha) Medicines Management Conference and the COSA–IPOS Annual Scientific Meeting this week The 60-year-old pharmacy group said it’s …
‘Rapid’ uptake of CF triple therapy
PBS listing of the combination medicine has led to improved quality of life for patients with cystic fibrosis (CF), says drug utilisation committee Nearly 90% of Australians prescriptions of cystic …
Fourfold jump in ADHD meds poisonings: study
“Just one double dose of clonidine can put a child in hospital”, research warns, as poisonings linked to ADHD medications surge Data from the NSW Poisons Information Centre (NSW PIC) …
November MIMS update
Some of the recent changes to the medicines landscape, with new products, presentations, indications and contraindications New Products Elafibranor (Iqirvo) and its main active metabolite GFT1007 are peroxisome proliferator-activated receptor …
Prescriber Bag reviewed
Furosemide, Covid-19 antiviral tablets cited in PBAC recommendations on items to be added to or removed from the bag All currently listed Prescriber Bag benefits remain suitable, except Covid-19 antiviral …
‘Consistent evidence’: GPP role saves money, improves health outcomes
GP pharmacists even helped patients on GLP-1s lose twice the amount of weight, a review exploring benefits of the role has found Medication reviews comprise a huge part of the …
Rising meds costs an issue
A new study has found women who received HMRs spent more on out-of-pocket medication costs over time than those who didn’t receive one Older women paid more out-of-pocket medication costs …
October MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Capivasertib (Truqap) is an inhibitor of the kinase activity of all 3 isoforms …
Empagliflozin PBS population expanded
Eligible patients more than doubled in line with largest trial on SGLT-2 inhibitors in CKD The PBS listing of Jardiance (empagliflozin 10mg) will be significantly expanded to include a broader …
Shortages, discontinuations seeing people on multiple medications
Semaglutide scarcity and other similar shortages have led to people doubling up on treatments, says diabetes educator and pharmacist Medicines shortages and discontinuations are leading to people concurrently taking multiple …
Oral versions of GLP-1s on the horizon
With benefits beyond glucose control for the “new kid on the block” in diabetes management, leading researcher foreshadows oral versions with less side effects New versions of GLP-1 receptor agonists …